ALL vs FOLD · P/E 4.9, $56.89B cap vs rev $528.3M
The Allstate Corporation (ALL) versus Amicus Therapeutics Inc (FOLD) — a side-by-side from cached financials, not a winner call.
The Allstate Corporation (ALL) is a insurance - property & casualty company listed on US.
Amicus Therapeutics Inc (FOLD) is a biotechnology company listed on US.
ALL does not have a complete income-statement cache yet.
Latest reported FOLD revenue for 2024-12-31 was $528.3M. Net income was -$56.1M. Revenue was up 32.3% from 2023-12-31 to 2024-12-31. FOLD currently screens at market cap $1.80B.
ALL currently screens at market cap $56.89B and trailing P/E 4.9. FOLD currently screens at market cap $1.80B.
Not investment advice. Open the ALL and FOLD stock pages for the full models.
Not investment advice.